???global.info.a_carregar???
Carina Santos Henriques is a Ph.D. student in Pharmaceutical Sciences at the University of Coimbra. She has a degree in Biomedical Sciences, with a minor in Molecular Biomedicine, from the University of Aveiro (2016) and a Master's degree in Molecular Biology and Genetics from the Faculty of Sciences of the University of Lisbon (2018). During her master's degree, she carried out her research work at the Center for Neuroscience and Cell Biology (CNC) of the University of Coimbra, whose work was awarded first place in the 3rd edition of BEB/Bluepharma award. Since 2019 she has been a research fellow at CNC, where she has been developing research in the field of gene therapy, with a focus on the development of viral and non-viral vectors for the treatment and modelling of neurodegenerative diseases. Since then, he has participated in different research projects, including projects in collaboration with international pharmaceutical companies (WAVE Life Sciences, UniQure, Blade Therapeutics and PTC Therapeutics), as well as in the biotechnological research infrastructure ViraVector.
Read full resume ↓
Identification

Personal identification

Full name
Carina Santos Henriques

Citation names

  • Henriques, Carina

Author identifiers

Ciência ID
5B12-3335-A348
ORCID iD
0000-0001-9974-754X

Email addresses

  • uc44868@uc.pt (Professional)
  • cshenriques@cnc.uc.pt (Professional)
  • chenriques4657@gmail.com (Personal)

Telephones

Telephone
  • 239855089 (Professional)

Addresses

  • Rua Larga, Faculty of Medicine, 3004-504, Coimbra, Coimbra, Portugal (Professional)

Websites

Knowledge fields

  • Medical and Health Sciences - Medical Biotechnology - Gene-based Diagnostics and Therapeutic Interventions
  • Medical and Health Sciences - Basic Medicine - Neurosciences
  • Natural sciences - Biological Sciences - Biology
  • Natural sciences - Biological Sciences - Cell Biology
  • Natural sciences - Biological Sciences - Molecular Biology
  • Medical and Health Sciences - Medical Biotechnology - Health-Related Biotechnology
  • Medical and Health Sciences - Medical Biotechnology - Technologies Involving the Manipulation of Cells, Tissues, Organs or the Whole Organism
  • Medical and Health Sciences - Basic Medicine - Human Genetics

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese (Mother tongue)
English Upper intermediate (B2) Upper intermediate (B2) Upper intermediate (B2) Advanced (C1) Upper intermediate (B2)
Education
Degree Classification
2021/01/01 - 2025/01/01
Ongoing
 Ciências Farmacêuticas (Doutoramento)
Universidade de Coimbra Faculdade de Farmácia, Portugal
"Towards Clinical Translation of an AAV-based silencing strategy for therapy of Machado-Joseph disease" (THESIS/DISSERTATION)
2023/03/28 - 2023/03/31
Concluded
 ESGCT 6th Annual Spring School (Outros)
European Society of Gene & Cell Therapy, Belgium
2022/11/08 - 2022/12/06
Concluded
 BioSTART 1st edition (Outros)
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2021/05/17 - 2021/05/28
Concluded
 Principles and Practice in Drug Development (Curso de doutoramento (conclusão de unidades curriculares))
Universidade de Coimbra, Portugal
2020/11 - 2021/05
Concluded
 IV Modular Structure training in Laboratory Animal Science (Outros)
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2021/04/19 - 2021/04/23
Concluded
 Advanced Therapies (Curso de doutoramento (conclusão de unidades curriculares))
Universidade de Coimbra, Portugal
2021/02/01 - 2021/02/05
Concluded
 High-Throughput Screening for Target and Drug Discovery (Curso de doutoramento (conclusão de unidades curriculares))
Universidade de Coimbra, Portugal
2016/09/13 - 2018/11/09
Concluded
 Biologia Molecular e Genética (Mestrado integrado)
Universidade de Lisboa Faculdade de Ciências, Portugal
"Modified-exosomes as gene delivery vectors for the treatment of Machado-Joseph disease" (THESIS/DISSERTATION)
 18
2018
Concluded
 Gestão de Resíduos Hospitalares Perigosos - Triagem e Acondicionamento (Outros)
ambiwaste, Portugal
2013/09 - 2016/06/28
Concluded
 Ciências Biomédicas (Licenciatura)
Major in Menor em Biomedicina Molecular
Universidade de Aveiro, Portugal
 15
2016
Concluded
 First Certificate in English (Outros)
Cambridge English Language Assessment, Russia
 B2
2016
Concluded
 Certificado de Formação Profissional (Outros)
Associação Formar para Salvar, Portugal
 18
Affiliation

Science

Category
Host institution 		Employer
2022/01 - Current Researcher (Research) Universidade de Coimbra, Portugal
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2019/12/30 - 2021/12/31 Researcher (Research) Universidade de Coimbra, Portugal
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2019/02/25 - 2019/12/24 Researcher (Research) Universidade de Coimbra, Portugal
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
(...)
2017/09/01 - 2018/10/09 Research Trainee (Research) Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2016/09 - 2017/01 Research Trainee (Research) Universidade de Lisboa, Portugal
Universidade de Lisboa Faculdade de Farmácia, Portugal
2016/07/01 - 2016/07/15 Research Trainee (Research) Universidade de Aveiro, Portugal
Universidade de Aveiro Instituto de Biomedicina, Portugal

Others

Category
Host institution 		Employer
2018/11/12 - 2019/02/27 Voluntary Researcher in continuation of MSc Thesis project Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Projects

Grant

Designation Funders
2019/02/25 - 2022/03 ViraVector - Viral Vector for Gene Transfer Core facility
CENTRO-01-0145-FEDER-022095
Research Fellow
Universidade de Coimbra - ViraVector, Portugal
 CENTRO 2020
Ongoing
2019/12/30 - 2021/12/31 BrainHealth 2020 - Detecção Precoce, Neuro-modulação e Terapias Avançadas para Neuropatologias
CENTRO-01-0145-FEDER-000008
Research Fellow
CENTRO 2020
2020/06 - 2020/11 Expedited validation and large-scale manufacture of a blowing device for collection with inactivation of samples for detection of SARS-CoV-2
269_596884125
Researcher
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal

Universidade de Coimbra Instituto de Investigação Interdisciplinar, Portugal

Universidade de Coimbra - ViraVector, Portugal
Fundação para a Ciência e a Tecnologia
2018/09 - 2019/06 Exosomes as gene delivery vectors for the treatment of Machado-Joseph disease/Spinocerebellar ataxia type 3
21163
Other
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
 AFM-Téléthon
Concluded

Contract

Designation Funders
2020/06 - 2022/12 mirSilencing
NA
Researcher
PTC Therapeutics Inc, United States
 PTC Therapeutics Inc
Concluded
2019/08 - 2020/05 Targeting mutant ATXN3 for the treatment of Spinocerebellar Ataxia 3 (SCA3) using allele-specific ASOs
NA
Researcher
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
 Wave Life Sciences
Concluded
2019/11 - 2020/01 A Therapeutic Strategy in Machado-Joseph Disease
CPD0020A01
Researcher
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
 Blade Therapeutics, Inc
Ongoing
2019/02 - 2019/09 Targeting ATXN3 for the treatment of Spinocerebellar Ataxia 3 (SCA3) using AAV5 and an artificial microRNA
NA
Researcher
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
 uniQure NV
Concluded

Other

Designation Funders
2020/04 - 2020/06 Covid-19 Lab @ CNC / ViraVector
NA
Researcher
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal

Universidade de Coimbra - ViraVector, Portugal
2020/03/26 - 2020/05 COVID-19 UC Lab
NA
Other
Universidade de Coimbra Laboratório de Análises Clínicas, Portugal
Ongoing
Outputs

Publications

Conference poster
  1. Leandro, Kevin; Rufino-Ramos, David; Lopes, Sara Monteiro; Pasqua, C; Santos, P; Silva, Ana Carolina; Lobo, Diana Duarte; et al. "Extracellular vesicles-mediated delivery of CRISPR/Cas9 systems to treat Machado-Joseph Disease/Spinocerebellar Ataxia Type 3". Paper presented in ESGCT 30th Congress, 2023.
  2. Lobo, Diana Duarte; Quintino, Luis; Silva, Ana Carolina; Henriques, Carina; Ribeiro, Rodrigo; Lopes, Sara Monteiro; Perdigão, Pedro; et al. "CRISPR activation as a therapeutic tool for Spinocerebellar ataxia type 3 (SCA3)". Paper presented in ESGCT 30th Congress, 2023.
  3. Silva, Ana Carolina; Henriques, Carina; Lobo, Diana Duarte; Pereira, Dina; Duarte, Sónia; Lopes, Sara Monteiro; Lopes, Miguel Monteiro; et al. "Investigating routes of administration and AAV serotypes for development of a gene-based therapy for spinocerebellar ataxia type 3 (SCA3)". Paper presented in ESGCT 30th Congress, 2023.
  4. Silva, Ana Carolina; Henriques, Carina; Lobo, Diana Duarte; Fernandes, Ana Rita; Lopes, Miguel Monteiro; Pereira, Dina; Duarte, Sónia; et al. "Allele-specific silencing of mutant ATXN3 rescues motor deficits and neuropathology in a severely impaired mouse model of spinocerebellar ataxia type 3 (SCA3) upon intra-cisterna magna administration". Paper presented in ESGCT 30th Congress, 2023.
  5. Leandro, Kevin; Rufino-Ramos, David; Lopes, Sara Monteiro; Pasqua, C; Santos P; Silva, Ana Carolina; Lobo, Diana Duarte; et al. "Extracellular vesicles-mediated delivery of CRISPR/Cas9 systems to treat Spinocerebellar Ataxia Type 3/Machado-Joseph Disease". Paper presented in CAG Triplet Repeat Disorders GRC, 2023.
  6. Rufino-Ramos, David; Leandro, Kevin; Vitor, Carmona; Martins, Ines Morgado; Albuquerque, Patrícia Rosado; Fernandes, Ana Rita; Henriques, Carina; et al. "Extracellular Vesicle-Based Delivery of Silencing Sequences for the Treatment of Machado-Joseph Disease". Paper presented in American Society of Gene Therapy (ASGCT) 26th Annual, 2023.
  7. David Rufino-Ramos; Leandro, Kevin; Albuquerque, Patrícia Rosado; Carmona, Vitor; Martins, Ines Morgado; Faro, Rosário; Henriques, Carina; et al. "Extracellular vesicles-based delivery of silencing seqeunces for the treatment of Machado-Joseph disease (MJD)/ Spinocerebellar Ataxia type-3 (SCA3)". Paper presented in ESGCT 29th Congress, 2022.
  8. Henriques, Carina; Lopes, Miguel Monteiro; Albuquerque, Patrícia Rosado; Rufino-Ramos, David; Gaspar, Laetitia S; Duarte, Diana Lobo; Silva, Ana Carolina; et al. "Production and isolation of natural and biologically active exo-AAVs for brain gene delivery". Paper presented in . ESGCT 29th Congress, 2022.
  9. Marcelo, Adriana; Afonso, Inês T; Afonso-Reis, Ricardo; Brito, David V.C.; Costa, Rafael G.; Rosa, Ana; Alves-Cruzeiro, Joao; et al. "From molecular mechanisms to therapy: a new lentiviral mouse model for Spinocerebellar ataxia type 2". Paper presented in XVII Meeting of the Portuguese Society for Neuroscience, 2021.
  10. Silva, Ana Carolina; Lobo, Diana Duarte; Henriques, Carina; Martins, Ines M; Lopes, Sara Monteiro; Duarte, Sonia P; Wagner, Elizabeth; Nobre, Rui Jorge; Pereira de Almeida, Luis. "Antinsense oligonucleotide mediated allele-specific silencing of mutant ATXN3 improves disease features in mouse models of Machado-Joseph Disease". Paper presented in XVII Meeting of the Portuguese Society for Neuroscience, 2021.
  11. Baganha, Rafael; Lopes, Miguel Monteiro; Henriques, Carina; Rufino-Ramos, David; Pereira de Almeida, Luis; Nobre, Rui Jorge. "Development of Affinity-based Purification Protocols for AAV Vectors Targeting the Central Nervous System". Paper presented in XVII Meeting of the Portuguese Society for Neuroscience, 2021.
  12. Coelho, Patricia; Lourenço, Ana Sofia; Ferreira, Ildete Luisa; Marinho, Daniela; Anjo, Sandra Isabel; Mas, Philippe J; Carvalho, Mario; et al. "Postsynatic SAPAP3 modulates mitochondrial function and dynamics". Paper presented in XVII Meeting of the Portuguese Society for Neuroscience, 2021.
  13. Silva, Ana Carolina; Lobo, Diana Duarte; Henriques, Carina; Martins, Maria Inês; Lopes, Sara Monteiro; Duarte, Sónia; Wagner, E; Nobre, Rui Jorge; Pereira de Almeida, Luis Fernando Morgado. "Allele-specific silencing of Machado-Joseph disease using antisense oligonucleotide therapeutics". Paper presented in 1st Symposium on Oligonucleotide Technologies and Therapeutics@Portugal, 2021.
  14. Afonso, Inês T.; Silva, Ana Carolina; Henriques, Carina; Lopes, Miguel; Baganha, Rafael; Lima, Patrícia; Koppenol, Rebekah; et al. "Brain distribution, spreading and tropism of a recently developed gene delivery system - mixCapAAV1/2vector". Paper presented in Annual International (bio)Medical Students Meeting (AIMS), 2021.
  15. Henriques, Carina; Lopes, Miguel; Albuquerque, Patrícia Rosado; Rufino-Ramos, David; Gaspar, Laetitia; Lobo, Diana Duarte; Duarte, Sónia; et al. "Extracellular vesicles-associated AAVs as new gene delivery vectors for the treatment of brain disorders". Paper presented in 3rd BEB Day, 2019.
  16. Leandro, Kevin; Rufino-Ramos, David; Henriques, Carina S.; Pereira de Almeida, Luis Fernando Morgado. "Density Gradient Centrifugation: an improved protocol for Extracellular Vesicles isolation". Paper presented in 1 st Annual Meeting in Pharmaceutical Sciences, 2019.
  17. Leandro, Kevin; Rufino-Ramos, David; Henriques, Carina S.; Pereira de Almeida, Luis Fernando Morgado. "Isolation of functional extracellular vesicles by sucrose gradient centrifugation". Paper presented in BEBDay 2019, 2019.
  18. Leandro, Kevin; Rufino-Ramos, David; Henriques, Carina S.; Pereira de Almeida, Luis Fernando Morgado. "Density Gradient Centrifugation: an improved protocol for Extracellular Vesicles isolation". Paper presented in CIBB Meeting 2019, 2019.
  19. Henriques, Carina; Lopes, Miguel; Albuquerque, Patrícia Rosado; Rufino-Ramos, David; Gaspar, Laeititia; Lobo, Diana Duarte; Duarte, Sónia; et al. "Extracellular vesicles-associated AAVs as gene delivery vectors for the treatment of brain diseases". Paper presented in 5th GEIVEX Symposium, 2019.
Journal article
  1. Henriques, Carina; Lopes, Miguel M; Silva, Ana C; Lobo, Diana D; Aron Badin, Romina; Hantraye, Philippe; Pereira de Almeida, Luís; Nobre, Rui Jorge. "Viral-based animal models in polyglutamine disorders". Brain (2024): http://dx.doi.org/10.1093/brain/awae012.
    10.1093/brain/awae012
  2. Rufino-Ramos, David; Albuquerque, Patrícia Rosado; Leandro, Kevin; Carmona, Vitor; Martins, Inês M.; Fernandes, Rita; Henriques, Carina; et al. "Extracellular vesicle-based delivery of silencing sequences for the treatment of Machado-Joseph disease/ Spinocerebellar Ataxia type 3". Molecular Therapy (2023):
    Published
  3. Carina Henriques; Rui Jorge Nobre; Diana D. Lobo; Sonia P. Duarte; Sara M. Lopes; Ana C. Silva; Miguel M. Lopes; et al. "miRNA-Mediated Knockdown of ATXN3 Alleviates Molecular Disease Hallmarks in a Mouse Model for Spinocerebellar Ataxia Type 3". Nucleic Acid Therapeutics (2022): https://doi.org/10.1089/nat.2021.0020.
    10.1089/nat.2021.0020
  4. Marcelo, Adriana; Afonso, Inês T.; Afonso-Reis, Ricardo; Brito, David V. C.; Costa, Rafael G.; Rosa, Ana; Alves-Cruzeiro, João; et al. "Autophagy in Spinocerebellar ataxia type 2, a dysregulated pathway, and a target for therapy". Cell Death & Disease 12 12 (2021): http://dx.doi.org/10.1038/s41419-021-04404-1.
    Published • 10.1038/s41419-021-04404-1
  5. Gaspar, Laetitia S.; Santana, Magda M.; Henriques, Carina; Pinto, Maria M.; Ribeiro-Rodrigues, Teresa M.; Girão, Henrique; Nobre, Rui Jorge; Pereira de Almeida, Luís. "Simple and Fast SEC-Based Protocol to Isolate Human Plasma-Derived Extracellular Vesicles for Transcriptional Research". Molecular Therapy - Methods & Clinical Development 18 (2020): 723-737. http://dx.doi.org/10.1016/j.omtm.2020.07.012.
    10.1016/j.omtm.2020.07.012
  6. Silva, Ana C; Lobo, Diana D; Martins, Inês M; Lopes, Sara M; Henriques, Carina; Duarte, Sónia P; Dodart, Jean-Cosme; Nobre, Rui Jorge; Pereira de Almeida, Luis. "Antisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disorders". Brain 143 2 (2019): 407-429. http://dx.doi.org/10.1093/brain/awz328.
    Published • 10.1093/brain/awz328
Newspaper article
  1. Vinhas, Ana Catarina; Vasconcelos-Ferreira, Ana; Henriques, Carina S.; Silva, Ana Carolina; Miranda, Catarina Oliveira; Henriques, Daniel; Oliveira, Daniela; et al. "Uma viagem rara", PÚBLICO, 2020, https://www.publico.pt/2020/02/28/ciencia/fotogaleria/viagem-rara-400481.
Thesis / Dissertation
  1. Henriques, Carina. "Modified-Exosomes as Gene Delivery Vectors for the Treatment of Machado-Joseph Disease". Master, Universidade de Lisboa Faculdade de Ciências, 2018. https://repositorio.ul.pt/handle/10451/35454.

Artistic / Performance

Theatre play
  1. Viegas, Teresa Ana; Marques, Andreia; Santos, Bárbara; Henriques, Carina S.; Rufino-Ramos, David; Lobo, Diana Duarte; Alfaiate, Inês; et al. 2019. Holy CIBB.
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2024/02 Extracellular vesicles delivery of CRISPR-Cas9 RNPs for therapeutic gene editing in Spinocerebellar Ataxia Type 3 54ª Reunião da Sociedade Portuguesa de Farmacologia, 42.ª Reunião de Farmacologia Clínica e 23ª Reunião de Toxicologia
(Lisboa, Portugal)
2024/02 Hacking biology: optimizing AAV-based gene delivery for enhanced brain regio-specific targeting 54ª Reunião da Sociedade Portuguesa de Farmacologia, 42.ª Reunião de Farmacologia Clínica e 23ª Reunião de Toxicologia
(Lisboa, Portugal)
2024/02 Generation of lentiviral-based mouse models of spinocerebellar ataxias: where to target? 42.ª Reunião de Farmacologia Clínica e 23ª Reunião de Toxicologia, Lisboa, Portugal, 7-9 February 2024
(Lisboa, Portugal)
2024/02 Targeted silencing via AAV9 polycistronic microRNA therapy rescues SCA3 molecular, neuropathological and motor deficits 54ª Reunião da Sociedade Portuguesa de Farmacologia, 42.ª Reunião de Farmacologia Clínica e 23ª Reunião de Toxicologia
(Lisboa, Portugal)
2023/11 Extracellular vesicles-mediated delivery of CRISPR/Cas9 systems to treat Machado-Joseph disease PharmaDay
(Coimbra, Portugal)
2023/11 Polycistronic artificial microRNAs delivery by AAV9 alleviate Spinocerebellar ataxia type 3(SCA3) PharmaDay
(Coimbra, Portugal)
2023/11 Targeting sirtuin-1 with CRISPR activation: a new therapeutic approach for SCA3 PharmaDay
(Coimbra, Portugal)
2023/06 Extracellular vesicles-mediated delivery of CRISPR/Cas9 systems to treat Spinocerebellar Ataxia Type 3/Machado-Joseph Disease CAG Triplet Repeat Disorders GRC
(Vermont, United States)
2023/05 Isolation of Natural and Biologically Active EV-AAVs for Brain Gene American Society of Gene Therapy (ASGCT) 26th Annual
(Los Angeles, United States)
2022/02 Upregulation of autophagy as a therapeutic strategy for SCA2 disease 52ª Reunião da Sociedade Portuguesa de Farmacologia, 40.ª Reunião de Farmacologia Clínica e 21ª Reunião de Toxicologia
(Porto, Portugal)
2022/02 Non-pathogenic viral vectors pseudotyped with the SARS-CoV-2 S protein to study drug repurposing and immunization strategies 52ª Reunião da Sociedade Portuguesa de Farmacologia, 40.ª Reunião de Farmacologia Clínica e 21ª Reunião de Toxicologia
(Porto, Portugal)
2021/02/19 Development Of Single-Step Affinity Chromatography Protocols For The Purification Of Adeno-Associated Viral Vectors 20ª Reunião de Toxicologia. A Sociedade Portuguesa de Farmacologia
(Lisboa, Portugal)
2021/02/18 MixcapAAV1/2 Vector: A Novel Gene Delivery System Distribution, Spreading And Tropism Analysis In Normal Mice 20ª Reunião de Toxicologia. A Sociedade Portuguesa de Farmacologia
(Lisboa, Portugal)
2021/02/18 Brain MicroRNAs In Plasma-Derived Extracellular Vesicles As Potential Biomarkers For Machado-Joseph Disease 20ª Reunião de Toxicologia. A Sociedade Portuguesa de Farmacologia
(Lisboa, Portugal)
2021/02/18 Allele-Specific Silencing Of Machado-Joseph Disease Using Antisense Oligonucleotide Therapeutics 20ª Reunião de Toxicologia. A Sociedade Portuguesa de Farmacologia
(Lisboa, Portugal)
2019/11/15 Extracellular vesicles-associated AAVs as gene delivery vectors for the treatment of brain disorders 1st Annual Meeting in Pharmaceutical Sciences
(Coimbra, Portugal)
2019/11 miRNA expression profile of plasma-derived extracellular vesicles distinguishes Machado-Joseph Disease patients from controls 23rd Annual Meeting, Portuguese Society of Human Genetics
(Coimbra, Portugal)
2019/11 Extracellular vesicles-associated AAVs as gene delivery vectors for the treatment of brain diseases (Flash poster presentation) 5th GEIVEX Symposium
2019/02/06 Extracellular vesicles-associated AAVs as gene delivery vectors for the treatment of brain diseases XLIX Reunião da Sociedade Portuguesa de Farmacologia, XXXVII Reunião de Farmacologia clínica, XVIII Reunião de toxicologia
(Porto, Portugal)

Event participation

Activity description
Type of event 		Event name
Institution / Organization
2018/11/19 - 2018/11/30 Divulgação do trabalho desenvolvido no CNC ao público através de conversas e atividades informais nos autocarros da SMTUC pela cidade de Coimbra, no contexto da Semana da Ciência e da Tecnologia 2018
Other
 Brain Buskers nos autocarros
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal

Association member

Society Organization name Role
2019/09 - Current GEIVEX (Grupo Español de Investigación e Innovación en Vesículas Extracelulares)
2017/04 - 2017/08 Board of European Students of Technology (BEST) Lisbon Corporate Relations
2017/03 - 2017/06 Re-food Nossa Senhora de Fátima, Lisboa Voluntary
2016/01 - 2017/01 Núcleo de Ciências Biomédicas - Associação Académica da Universidade de Aveiro (NECiB-AAUAv) Marketing and Communication Department

Mentoring / Tutoring

Topic Student name
2014/09 - 2016/06 Programa de Tutoria / PT-UA Ana Claudio, Margarida Vale, Rita Soares, Ivana Martins, Jéssica Santos, Maria Pinto,Tânia Gonçalves
2015/09 - 2016/01 Erasmus Student Network (ESN) Aveiro Szymon Fraszczyk
Distinctions

Award

2023 Meritorious Abstract Travel Award
American Society of Gene & Cell Therapy, United States
2019 Winner of 3rd BEB/BluePharma award
Bluepharma, Portugal